In the last trading session, 1.55 million Bio-Path Holdings Inc (NASDAQ:BPTH) shares changed hands as the company’s beta touched 0.09. With the company’s per share price at $1.11 changed hands at -$0.15 or -11.90% during last session, the market valuation stood at $4.05M. BPTH’s last price was a discount, traded about -981.08% off its 52-week high of $12.00. The share price had its 52-week low at $0.59, which suggests the last value was 46.85% up since then. When we look at Bio-Path Holdings Inc’s average trading volume, we note the 10-day average is 11.89 million shares, with the 3-month average coming to 3.02 million.
Analysts gave the Bio-Path Holdings Inc (BPTH) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended BPTH as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Bio-Path Holdings Inc’s EPS for the current quarter is expected to be -0.37.
Bio-Path Holdings Inc (NASDAQ:BPTH) trade information
Instantly BPTH was in red as seen at the end of in last trading. With action 65.70%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -88.01%, with the 5-day performance at 65.70% in the green. However, in the 30-day time frame, Bio-Path Holdings Inc (NASDAQ:BPTH) is 38.92% up. Looking at the short shares, we see there were 77764.0 shares sold at short interest cover period of 0.03 days.
Bio-Path Holdings Inc (BPTH) estimates and forecasts
Data shows that the Bio-Path Holdings Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -47.14% over the past 6 months, a 90.57% in annual growth rate that is considerably higher than the industry average of 16.40%.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 34.89%. The 2024 estimates are for Bio-Path Holdings Inc earnings to increase by 90.57%.
BPTH Dividends
Bio-Path Holdings Inc is expected to release its next quarterly earnings report in January.
Bio-Path Holdings Inc (NASDAQ:BPTH)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.04% of Bio-Path Holdings Inc shares while 1.08% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 1.08%.
